Notice_of_Intent_to_Sole_Source_OS179260.pdf

Pursuant to the authority of FAR 13.106-1(b)(1)(i), the Contracting Officer may solicit from one source if the Contracting Officer determines that the circumstances of the contract action deem only one source is reasonably available. The Department of Health and Human Services

(DHHS), Program Support Center (PSC), Acquisition Management Services (AMS), on behalf of the Asst. Secretary for Planning and Evaluation (ASPE) intends to sole source to:

James K. Hammitt, Ph.D.

Harvard Center for Risk Analysis

718 Huntington Avenue

Boston, MA 02115

In accordance with FAR 5.207(c), ASPE’s requirement is described as follows:

(1) National Stock Number (NSN): N/A

(2) Specification: Regulatory Impact Analysis Guidelines, Retrospective Analysis, and

Technical Assistance – REMIS SP-16-028

(3) Manufacturer: N/A

(4) Functional Description:

(5) Predominant material of manufacture: N/A

(6) Quantity: N/A

(7) Unit of issue: N/A

(8) Destination information:

HHS/ASPE

200 Independence Ave., SW

Washington, DC 20201

(9) Delivery Schedule: N/A

(10) Duration of the contract period: Data of Award through 12 Months

(11) Sustainable acquisition requirements: N/A

(12) Description of Procedure: This is a pre-solicitation notice of intent to sole source. This is not a solicitation for competitive proposal. No solicitation document is available. The anticipated award date is no later than September 23, 2016.

(13) Architect-Engineer Project: N/A

(14) Trade Agreement Clauses: N/A

(15) Sole Source Justification: The Department of Health and Human Services (DHHS), Program Support Center (PSC), Acquisition Management Services (AMS), on behalf of the

Asst. Secretary for Planning and Evaluation (ASPE) intends to sole source to:

James K. Hammitt, Ph.D.

Harvard Center for Risk Analysis

718 Huntington Avenue

Boston, MA 02115

Dr. James Hammitt is a world-renowned researcher in risk analysis and is a widely recognized authority on non-market valuation of health and environmental regulations and the characterization of social preferences over health risks using revealed preference, stated-preference, and health-utility methods. He has served as an academic researcher, lecturer, and professor at Harvard University for over 20 years and is current director of the Harvard

Center for Risk Analysis. Dr. Hammitt served on six National Academies of Sciences panels, more than a dozen advisory committees to the government agencies, including senior advisor to the Office of Science/ASPE, is a fellow of the Society for Risk Analysis, and in 2015 received the SRA’s Distinguished Achievement Award for “for extraordinary achievement in science or public policy relating to risk analysis.”

Dr. Hammitt has written extensively for three decades on decision and risk analysis, public policy, health-risk management, mathematical modeling, and assessing regulatory impact analyses. His body of work includes the publications listed below. The nature of this contractor requires a direct and in-depth knowledge of creating and conducting regulatory impact analysis and retrospective reviews, expert knowledge of the literature related to the effect of labeling trans fat, and experience working with ASPE senior staff on additional technical assistance. Dr. Hammitt is well versed in these issues, having worked directly with

ASPE as one of the authors of Guidelines for Regulatory Impact Analysis, prepared for the

Office of Science and Data Policy. His extensive experience in both academic and policy research and his knowledge of government regulation and policymaking within HHS make

Dr. James Hammitt uniquely qualified to provide expert advice to this effort.

In addition to the fact that Dr. Hammitt is uniquely qualified for this work, there is urgency in getting this procurement awarded and the work completed. The analysis that is required is time sensitive in that it is needed for imminent guidance and regulation development.

(16) This is not a solicitation for competitive proposal. No solicitation document is available.

All responsible sources that have determined that they can provide the same services may submit product information and a capabilities statement. The email subject line must reference OS179260 – Regulatory Impact. All responses are due by September 14, 2016 at

1:00 PM Eastern Time and can be sent to Epe Pacantara at Epe.Pacantara@psc.hhs.gov. A determination by the Government not to compete this proposed contract base upon responses to this notice is solely within the discretion of the government.

mailto:Epe.Pacantara@psc.hhs.gov